HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of apoptotic cell death in three human osteosarcoma cell lines by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone) (MGBCP).

Abstract
Our previous experiments have shown that methylglyoxal bis(cyclopentylamidinohydrazone) (MGBCP), a polyamine synthesis inhibitor, suppresses the growth of osteosarcoma cells repressing their intracellular polyamine levels, and that this inhibition of cell growth is only partially reversed by the addition of polyamines. In the present study, we found evidence indicating that the incomplete recovery of cell growth by the addition of polyamines to the polyamine-depleted cells was due to programmed cell death (apoptosis) induced by MGBCP. Morphological changes showing blebbing and chromatin condensation were observed in MGBCP-treated cells, and hypodiploid subpopulations containing apoptotic cells were clearly visible in the profile of flow cytometric analysis. Characteristic oligonucleosomal-sized fragments were increased as the concentration of MGBCP was increased. The results presented here suggest that in addition to reducing the growth rates, MGBCP can induce apoptotic cell death in three human osteosarcoma cell lines.
AuthorsK Mori, H Hibasami, N Satoh, J Sonoda, T Yamasaki, M Tajima, S Higuchi, H Wakabayashi, H Kaneko, A Uchida, K Nakashima
JournalAnticancer research (Anticancer Res) 1997 Jul-Aug Vol. 17 Issue 4A Pg. 2385-9 ISSN: 0250-7005 [Print] Greece
PMID9252651 (Publication Type: Journal Article)
Chemical References
  • Polyamines
  • methylglyoxal bis(cyclopentylamidinohydrazone)
  • Mitoguazone
Topics
  • Apoptosis (drug effects)
  • DNA Fragmentation (drug effects)
  • Humans
  • Mitoguazone (analogs & derivatives, pharmacology)
  • Osteosarcoma (pathology)
  • Polyamines (metabolism)
  • Tumor Cells, Cultured (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: